These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Goldstein A; Naidu A Mol Pharmacol; 1989 Aug; 36(2):265-72. PubMed ID: 2549383 [TBL] [Abstract][Full Text] [Related]
5. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists. Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176 [TBL] [Abstract][Full Text] [Related]
6. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency. Cox BM; Chavkin C Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144 [No Abstract] [Full Text] [Related]
7. QSAR analysis of acetylcholinesterase inhibitors by use of structure similarity methods. Jerman-Blazic B; Fabic-Petrac I; Pecar S; Stalc A Prog Clin Biol Res; 1989; 291():213-6. PubMed ID: 2726849 [TBL] [Abstract][Full Text] [Related]
8. [Structure and conformation-activity relationships of cyclic acetylcholine analogues / 12th communication: Synthesis and cholinergic properties of stereoisomeric 3-acetoxythiacyclohexanes (author's transl)]. Lambrecht G Arzneimittelforschung; 1981; 31(4):634-40. PubMed ID: 6972770 [TBL] [Abstract][Full Text] [Related]
10. Rational design and biological properties of highly specific mu and delta opioid peptides. Roques BP; Fournié-Zaluski MC; Gacel G; David M; Meunier JC; Maigret B; Morgat JL Adv Biochem Psychopharmacol; 1982; 33():321-31. PubMed ID: 6289629 [No Abstract] [Full Text] [Related]
11. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity. Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers. Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501 [TBL] [Abstract][Full Text] [Related]
13. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum. Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594 [No Abstract] [Full Text] [Related]
14. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor. Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547 [TBL] [Abstract][Full Text] [Related]
15. N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists. Thomas JB; Zheng X; Mascarella SW; Rothman RB; Dersch CM; Partilla JS; Flippen-Anderson JL; George CF; Cantrell BE; Zimmerman DM; Carroll FI J Med Chem; 1998 Oct; 41(21):4143-9. PubMed ID: 9767649 [TBL] [Abstract][Full Text] [Related]
16. [Infusing drug concentration- and speed-response curves]. Zhou YY; Tang ZG; Jing LP; He JH; Chen D; Hou DY; Chu L Zhongguo Yao Li Xue Bao; 1987 Sep; 8(5):385-9. PubMed ID: 3450170 [No Abstract] [Full Text] [Related]
17. Site-dependent effects of ions on mu-, delta- and kappa-opioid binding in suspensions of guinea-pig brain membranes. Robson LE; Paterson SJ; Kosterlitz HW NIDA Res Monogr; 1986; 75():61-3. PubMed ID: 2829007 [TBL] [Abstract][Full Text] [Related]
18. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine. Ward SJ; LoPresti D; James DW J Pharmacol Exp Ther; 1986 Aug; 238(2):625-31. PubMed ID: 3016244 [TBL] [Abstract][Full Text] [Related]
19. Chirality and its implications in transdermal drug development. Reddy IK; Kommuru TR; Zaghloul AA; Khan MA Crit Rev Ther Drug Carrier Syst; 2000; 17(4):285-325. PubMed ID: 10958245 [TBL] [Abstract][Full Text] [Related]
20. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group. Traynor JR; Guo L; Coop A; Lewis JW; Woods JH J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]